Differences in contemporary biopsy Gleason score distribution in large cohorts of men diagnosed with prostate cancer from China and Canada

Autor: L. Dong, W. Xu, D. Woon, C. Kuk, Y. Zhu, A. Erlich, Z. Ma, O. Shi, B. Dong, M. Nesbitt, S.V. Carlsson, G. Kulkarni, R. Hamilton, A. Finelli, N.E. Fleshner, A. Toi, T.H. Van Der Kwast, W. Xue, A.R Zlotta

Publikováno v: European Urology Open Science, Vol 19, Iss , Pp e1700- (2020)

Externí odkaz: https://doaj.org/article/ee058112ce3e42488514a69f45709ae5

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

SEPERA – a novel artificial intelligence-based side-specific extra-prostatic extension risk assessment tool for patients undergoing radical prostatectomy

Autor: J. Kwong, A. Khondker, E. Meng, N. Taylor, N. Perlis, G.S. Kulkarni, R.J. Hamilton, N.E. Fleshner, A. Finelli, T.H. Van Der Kwast, J.R. Srigley, M. Jamal, V. Colinet, A. Peltier, R. Diamand, Y. Lefebvre, Q. Mandoorah, R. Sanchez-Salas, P. Macek, X. Cathelineau, M. Eklund, A.E.W. Johnson, A.H. Feifer, A.R. Zlotta

Publikováno v: European Urology. 83:S685-S686

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0dc559203f9cbfde594259abaa547e5d
https://doi.org/10.1016/s0302-2838(23)00527-4

Papillary urothelial neoplasm of low malignant potential (PUN-LMP)

Autor: Karin Plass, Virginia Hernández, Richard Sylvester, H.M. Bruins, Anouk E. Hentschel, Nicolai A. Huebner, Isabel Alemany, Johannes Breyer, Dimitrios Volanis, Morgan Rouprêt, Luca Lunelli, Judith Bosschieter, Shahrokh F. Shariat, Marko Babjuk, Matthias Evert, David Ashabere, Sebastian Mannweiler, J.D. Subiela Henríquez, Jakko A. Nieuwenhuijzen, Venkata R.M. Kusuma, T.H. Van Der Kwast, Alexandre R. Zlotta, Laura S. Mertens, Olivier Cussenot, Lenka Bauerová, Jaromir Hacek, Andrea Haitel, A.G. Van Der Heijden, James N'Dow, B.W.G. Van Rhijn, A. Scavarda-Lamberti, E. de la Peña, Daniel Cohen, Eva Compérat, S. El Sheikh, Willemien Runneboom, Jean François Coté, Joan Palou, Antonin Brisuda, Maximilian Seles, José Rubio-Briones, Oscar Rodríguez, A.H. Mostafid, Michael Pešl, Viktor Soukup, Johannes Bründl, Diana Turturica, Francesca Pisano, Paolo Gontero, Carlos Llorente, Ferran Algaba, Lambertus A. Kiemeney, C.A. Hulsbergen Van De Kaa, Otakar Čapoun, Ana Calatrava, Francesco Soria, Sonja Herdegen, Richard Zigeuner, Juliette Cotte, J. Domínguez-Escrig, Maximilian Burger, Luca Molinaro

Publikováno v: Urologic Oncology-Seminars and Original Investigations, 38, 5, pp. 440-448
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Urologic Oncology-Seminars and Original Investigations, 38, 440-448
Hentschel, A E, van Rhijn, B W G, Bründl, J, Compérat, E M, Plass, K, Rodríguez, O, Henríquez, J D S, Hernández, V, de la Peña, E, Alemany, I, Turturica, D, Pisano, F, Soria, F, Čapoun, O, Bauerová, L, Pešl, M, Bruins, H M, Runneboom, W, Herdegen, S, Breyer, J, Brisuda, A, Scavarda-Lamberti, A, Calatrava, A, Rubio-Briones, J, Seles, M, Mannweiler, S, Bosschieter, J, Kusuma, V R M, Ashabere, D, Huebner, N, Cotte, J, Mertens, L S, Cohen, D, Lunelli, L, Cussenot, O, Sheikh, S E, Volanis, D, Coté, J-F, Rouprêt, M, Haitel, A, Shariat, S F, Mostafid, A H, Nieuwenhuijzen, J A, Zigeuner, R, Dominguez-Escrig, J L, Hacek, J, Zlotta, A R, Burger, M, Evert, M, Hulsbergen-van de Kaa, C A, van der Heijden, A G, Kiemeney, L A L M, Soukup, V, Molinaro, L, Gontero, P, Llorente, C, Algaba, F, Palou, J, N'Dow, J, Babjuk, M, van der Kwast, T H & Sylvester, R J 2020, ' Papillary urothelial neoplasm of low malignant potential (PUN-LMP) : Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019? ', Urologic Oncology, vol. 38, no. 5, doi: 10.1016/j.urolonc.2019.10.002, pp. 440-448 . https://doi.org/10.1016/j.urolonc.2019.10.002
Urologic Oncology, 38(5):doi: 10.1016/j.urolonc.2019.10.002, 440-448. Elsevier Inc.

Background: Papillary urothelial neoplasm of low malignant potential (PUN-LMP) was introduced as a noninvasive, noncancerous lesion and a separate grade category in 1998. Subsequently, PUN-LMP was reconfirmed by World Health Organization (WHO) 2004 a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f03357d0e9fec95b26b69fe1c0b638b6
http://www.scopus.com/inward/record.url?scp=85075511712&partnerID=8YFLogxK

Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer

Autor: Sangeet Ghai, Neil Fleshner, Andrew J. Evans, Narhari Timilshina, J Morris, Alexandre R. Zlotta, Maria Komisarenko, Antonio Finelli, T.H. Van Der Kwast, Kunal Jain, Nathan Perlis, Shabbir M.H. Alibhai, Lisa Martin, Robert J. Hamilton, Girish Kulkarni

Publikováno v: Prostate Cancer and Prostatic Diseases. 24:69-76

BACKGROUND Although 5-alpha-reductase inhibitors (5ARIs) have been shown to benefit men with prostate cancer (PCa) on active surveillance (AS), their long-term safety remains controversial. Our objective is to describe the long-term association of 5A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7de5616883dc2351953f74146a33f96d
https://doi.org/10.1038/s41391-020-0218-2